亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Treatment of Hypertension

医学 坎德萨坦 氯沙利酮 氢氯噻嗪 血压 内科学 阿替洛尔 氨氯地平 钙通道阻滞剂 噻嗪 心脏病学 利尿剂 内分泌学 血管紧张素II
作者
Robert M. Carey,Andrew E. Moran,Paul K. Whelton
出处
期刊:JAMA [American Medical Association]
卷期号:328 (18): 1849-1849 被引量:199
标识
DOI:10.1001/jama.2022.19590
摘要

Importance Hypertension, defined as persistent systolic blood pressure (SBP) at least 130 mm Hg or diastolic BP (DBP) at least 80 mm Hg, affects approximately 116 million adults in the US and more than 1 billion adults worldwide. Hypertension is associated with increased risk of cardiovascular disease (CVD) events (coronary heart disease, heart failure, and stroke) and death. Observations First-line therapy for hypertension is lifestyle modification, including weight loss, healthy dietary pattern that includes low sodium and high potassium intake, physical activity, and moderation or elimination of alcohol consumption. The BP-lowering effects of individual lifestyle components are partially additive and enhance the efficacy of pharmacologic therapy. The decision to initiate antihypertensive medication should be based on the level of BP and the presence of high atherosclerotic CVD risk. First-line drug therapy for hypertension consists of a thiazide or thiazidelike diuretic such as hydrochlorothiazide or chlorthalidone, an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker such as enalapril or candesartan, and a calcium channel blocker such as amlodipine and should be titrated according to office and home SBP/DBP levels to achieve in most people an SBP/DBP target (<130/80 mm Hg for adults <65 years and SBP <130 mm Hg in adults ≥65 years). Randomized clinical trials have established the efficacy of BP lowering to reduce the risk of CVD morbidity and mortality. An SBP reduction of 10 mm Hg decreases risk of CVD events by approximately 20% to 30%. Despite the benefits of BP control, only 44% of US adults with hypertension have their SBP/DBP controlled to less than 140/90 mm Hg. Conclusions and Relevance Hypertension affects approximately 116 million adults in the US and more than 1 billion adults worldwide and is a leading cause of CVD morbidity and mortality. First-line therapy for hypertension is lifestyle modification, consisting of weight loss, dietary sodium reduction and potassium supplementation, healthy dietary pattern, physical activity, and limited alcohol consumption. When drug therapy is required, first-line therapies are thiazide or thiazidelike diuretics, angiotensin-converting enzyme inhibitor or angiotensin receptor blockers, and calcium channel blockers.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
MchemG应助科研通管家采纳,获得10
6秒前
量子星尘发布了新的文献求助30
12秒前
16秒前
量子星尘发布了新的文献求助10
21秒前
22秒前
32秒前
量子星尘发布了新的文献求助10
37秒前
43秒前
量子星尘发布了新的文献求助10
53秒前
58秒前
1分钟前
量子星尘发布了新的文献求助10
1分钟前
1分钟前
1分钟前
阿泽完成签到,获得积分10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
1分钟前
tigerli发布了新的文献求助10
1分钟前
1分钟前
田様应助李亚宁采纳,获得10
1分钟前
量子星尘发布了新的文献求助10
1分钟前
充电宝应助tigerli采纳,获得10
1分钟前
1分钟前
量子星尘发布了新的文献求助10
1分钟前
1分钟前
量子星尘发布了新的文献求助10
2分钟前
量子星尘发布了新的文献求助10
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
Yound发布了新的文献求助10
2分钟前
一路微笑完成签到,获得积分10
2分钟前
李亚宁发布了新的文献求助10
2分钟前
量子星尘发布了新的文献求助10
2分钟前
2分钟前
量子星尘发布了新的文献求助10
2分钟前
2分钟前
坚强白凝发布了新的文献求助10
2分钟前
量子星尘发布了新的文献求助10
3分钟前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
Statistical Methods for the Social Sciences, Global Edition, 6th edition 600
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
ALUMINUM STANDARDS AND DATA 500
Walter Gilbert: Selected Works 500
岡本唐貴自伝的回想画集 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3666365
求助须知:如何正确求助?哪些是违规求助? 3225436
关于积分的说明 9762962
捐赠科研通 2935270
什么是DOI,文献DOI怎么找? 1607588
邀请新用户注册赠送积分活动 759266
科研通“疑难数据库(出版商)”最低求助积分说明 735188